• FDA’s Landmark Win, Garland’s Contempt Drama, G7’s Ukraine Strategy, Supreme Court Gun Ruling

  • Jun 18 2024
  • Durée: 18 min
  • Podcast

Page de couverture de FDA’s Landmark Win, Garland’s Contempt Drama, G7’s Ukraine Strategy, Supreme Court Gun Ruling

FDA’s Landmark Win, Garland’s Contempt Drama, G7’s Ukraine Strategy, Supreme Court Gun Ruling

Écouter gratuitement

Voir les détails du balado

  • Résumé

  • SEND ME A TEXT MESSAGE NOW

    Is democracy on the brink, or can we stand together to save it? In this compelling episode, I navigate the turbulent waters of global chaos, zeroing in on significant political and legal developments that shape our world. From the Supreme Court's landmark ruling on the FDA's regulation of the abortion pill, to the House's controversial contempt referral of Attorney General Merrick Garland, and the DOJ's decision. I dissect the layers of these pivotal moments. You'll hear my unfiltered reactions and thoughtful analyses, shedding light on the dynamic tensions between reproductive rights, executive privilege, and political strategy.

    Additionally, I touch on the recent G7 meeting where global leaders decide on how to support Ukraine using funds from Russia? I offer a nuanced perspective on international cooperation in times of conflict. Join me for a deep dive into these critical issues as I celebrate judicial victories, question the motives of political maneuvers, and explore the broader implications for democracy and justice. This episode promises to be a thought-provoking journey through some of the most pressing topics of our time.

    AWorldGoneMadPodcast@gmail.com
    Voir plus Voir moins
activate_primeday_promo_in_buybox_DT
Sciences politiques
Voir plus Voir moins

Ce que les auditeurs disent de FDA’s Landmark Win, Garland’s Contempt Drama, G7’s Ukraine Strategy, Supreme Court Gun Ruling

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.

Évaluations sur Audible.ca

Évaluations sur Amazon.ca
Il n'y a pas encore de critiques pour ce titre.